1. Question of The Week -- October 29, 2020

    Question of The Week -- October 29, 2020

    As outlined this past week by The Boston Globe, executives and board members at pharmaceutical companies involved in the development of Covid-19 vaccines have been amassing small fortunes during the past few months through the sale of stock they own in those companies -- benefiting from public speculation on the efficacy of such vaccines.  Although legally, on its face, there is nothing wrong with such sales, is it time for the SEC to take a closer look at placing restrictions on stock sales by insiders at pharmaceutical companies?

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      Board Recruitment Publication, BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
  2. Topics Mentioned